- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-09-28
DOI
10.1021/acs.jmedchem.1c00566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
- (2021) Ewelina Weglarz-Tomczak et al. Scientific Reports
- Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids
- (2021) Shashi Kant Tiwari et al. Stem Cell Reports
- Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
- (2021) Mark Dittmar et al. Cell Reports
- METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection
- (2021) Na Li et al. Cell Reports
- ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
- (2021) GuanQun Liu et al. Nature Microbiology
- Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
- (2021) Woo Dae Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
- (2021) Kangsa Amporndanai et al. Nature Communications
- Novel coronavirus: From discovery to clinical diagnostics
- (2020) Tung Phan INFECTION GENETICS AND EVOLUTION
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease
- (2020) Brendan T Freitas et al. ACS Infectious Diseases
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
- (2020) Seong Woo Choi et al. ANTIVIRAL RESEARCH
- Cholesterol 25‐Hydroxylase inhibits SARS ‐CoV‐2 and other coronaviruses by depleting membrane cholesterol
- (2020) Shaobo Wang et al. EMBO JOURNAL
- Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
- (2020) Theresa Klemm et al. EMBO JOURNAL
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
- (2018) Young-A Heo et al. DRUGS
- Lipophilic Efficiency as an Important Metric in Drug Design
- (2018) Ted W. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead-like Drugs: A Perspective
- (2018) Brian Raymer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
- (2017) Matthew M. Weiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
- (2017) Steve Kanters et al. Lancet HIV
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
- (2016) Tomonari Muramatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Simeprevir and sofosbuvir for treatment of hepatitis C infection
- (2015) Shelby Chopp et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Simeprevir: A Review of Its Use in Patients with Chronic Hepatitis C Virus Infection
- (2015) Mark Sanford DRUGS
- The role of ligand efficiency metrics in drug discovery
- (2014) Andrew L. Hopkins et al. NATURE REVIEWS DRUG DISCOVERY
- Darunavir: A Review of Its Use in the Management of HIV-1 Infection
- (2013) Emma D. Deeks DRUGS
- A safe lithium mimetic for bipolar disorder
- (2013) Nisha Singh et al. Nature Communications
- Using the Golden Triangle to optimize clearance and oral absorption
- (2009) Ted W. Johnson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Saquinavir, the pioneer antiretroviral protease inhibitor
- (2009) Charles JL la Porte Expert Opinion on Drug Metabolism & Toxicology
- Antioxidant Activity of the Anti-Inflammatory Compound Ebselen: A Reversible Cyclization Pathway via Selenenic and Seleninic Acid Intermediates
- (2008) Bani Kanta Sarma et al. CHEMISTRY-A EUROPEAN JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now